Crinetics Pharmaceuticals, Inc. ($CRNX)
Filing Information
| Accession Number | 0001628280-26-019503 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 18, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
9,911
Total Value
$370,411.47
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Mar 16, 2026 | Sale | 5,950 | $37.11 | $220,804.50 | 115,979 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 16, 2026 | Sale | 3,961 | $37.77 | $149,606.97 | 112,018 | Direct | โ | View Details |